Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

A picture of radiologists looking at a screen showing the restaging of the HNSCC

Study Highlights the Potential of Radiomics in Medical Intervention

A recent study conducted by the Medical University of Innsbruck highlights the potential of radiomics in exploring the impacts of Radiochemotherapy (RCT) on patients with Head and Neck Squamous Cell Carcinoma (HNSCC). This study is the first to explore short-term RCT-induced skeletal muscle alterations after RCT in HNSCC patients applying radiomics, a data-driven approach aiming at extracting and processing quantitative data to analyze image-based information.

With the help of the mint Lesion™ Radiomics module, the research examined radiation-induced changes in the sternocleidomastoideus muscle (SCM) and paravertebral musculature (PVM) post-RCT. Analyzing key radiomic features like volume, mean positivity of pixels, and uniformity the study team was able to confirm the optimal window of 6 to 12 weeks for salvage surgery post-RCT, minimizing the risk of complications due to tissue fibrosis. These findings further showcase how radiomics can enhance medical treatment strategies and indicate a bright path for ongoing research in this area.

Read more about the study

Related Resources

Related Resources

Radiologic Analysis of COVID-19 Infection

65 minute(s)

In a recent webcast, Dr. Ronald Korn, Founder and CMO at Imaging Endpoints and Kelie Williams Luby, VP Clinical Trials Software at Mint Medical,…

Creating evidence to tackle COVID-19

Our COVID-19 reading template is in use for two weeks, and its usage is multiplying. We are grateful for the close cooperation and feedback from…

Potential of using structured data from clinical trials and routine for AI and radiomics research

Dr. Nils Grosse Hokamp shares his experience of using mint Lesion™ at the University Hospital Cologne in this brief interview. He talks about how they…